Printer Friendly
The Free Library
14,632,679 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Research and Markets: Disease Specific Test Reagents Clinical Trial Analysis: Allergy, Anaemia/Vitamins, Rheumatoid Disease, Auto-Immune Disease.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
 -- Research and Markets (http://www.researchandmarkets.com/research/d97af4/disease_specific_t) has announced the addition of Global Markets Direct's new report "Disease Specific Test Reagents Clinical Trial Analysis" to their offering.

Disease Specific Test Reagents Clinical Trial Analysis

Disease Specific Test Reagents Clinical Trials Analysis is an essential source of data and information pertaining per·tain  
intr.v. per·tained, per·tain·ing, per·tains
1. To have reference; relate: evidence that pertains to the accident.

2.
 to product clinical trials being carried out by Disease Specific Test Reagents manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

* The report provides analysis and review of the key clinical trials being carried out globally and across key Disease Specific Test Reagents market categories - Allergy allergy, hypersensitive reaction of the body tissues of certain individuals to certain substances that, in similar amounts and circumstances, are innocuous to other persons. Allergens, or allergy-causing substances, can be airborne substances (e.g. , Anaemia/Vitamins, Rheumatoid rheumatoid /rheu·ma·toid/ (roo´mah-toid)
1. resembling rheumatism.

2. associated with rheumatoid arthritis.


rheu·ma·toid
adj.
1. Of or resembling rheumatism.
 Disease, Auto-Immune Disease.

* The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's it's  

1. Contraction of it is.

2. Contraction of it has. See Usage Note at its.


it's it is or it has
it's be ~have
 being investigated for etc.

* The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym acronym: see abbreviation.


A word typically made up of the first letters of two or more words; for example, BASIC stands for "Beginners All purpose Symbolic Instruction Code.
, purpose, inclusion and exclusion criteria exclusion criteria AIDS Donor exclusion criteria, see there , description, design, intervention A procedure used in a lawsuit by which the court allows a third person who was not originally a party to the suit to become a party, by joining with either the plaintiff or the defendant. , investigator information, primary and secondary end-points and trial results.

* The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

* Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.

* Stay ahead of the information curve in the fast changing Disease Specific Test Reagents market.

* Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.

* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

* Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.

* Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

For more information visit http://www.researchandmarkets.com/research/d97af4/disease_specific_t
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 5, 2009
Words:324
Previous Article:Research and Markets: New Report Examines the Future Prospects of the Anesthesia and Respiratory Devices Market with Forecast to 2015.
Next Article:GrapeCity Releases ActiveReports 6, Latest Version of the Premier .NET Framework Reporting Tool for Microsoft Visual Studio.
Topics:

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles